Two Sigma Investments, LP Bolt Biotherapeutics, Inc. Transaction History

Two Sigma Investments, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$1.41 - $2.91 $23,903 - $49,333	16,953 Added 95.24%	34,754 $71,000
Q1 2022 May 16, 2022	SELL	$2.74 - $4.82 $21,095 - $37,109	-7,699 Reduced 30.19%	17,801 $49,000
Q4 2021 Feb 14, 2022	BUY	$4.19 - $13.97 $106,845 - $356,235	25,500 New	25,500 $125,000
Q3 2021 Nov 15, 2021	SELL	$11.15 - $18.6 $136,966 - $228,482	-12,284 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$15.4 - $31.46 $189,173 - $386,454	12,284 New	12,284 $190,000

19.1M

Ticker BOLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,641,500
Market Cap $18.8M
Description
Bolt Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the development of immuno-oncology agents to target tumor cells for elimination by the immune system. The company is developing BDC-1001, a human epidermal growth factor receptor 2 (HER2), which is in Phase I/II clinical trial for the treatment of patients with HER2-e...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.